1 Within the past decade, longer-acting GLP-1 RA formulations entered the market as once-weekly, self-administered injectable pens most notably, semaglutide
Overall Clinical Fit: "More weight loss on average" does not automatically mean "best choice for every patient." Your doctor will consider medication tolerability, insurance coverage, existing comorbidities, and your personal medical history when deciding between the two
Toxins 3
This approach supports nutrient-dense formulations where protein and fiber remain the heroes, while sweetness plays a subtle, complementary role rather than dominating the taste experience
For GLP-1 users experiencing joint discomfort during weight loss, curcumin provides a natural alternative to daily NSAID use
2023 Dec 14;389(24):2221-2232